Allscripts Acute Care Users Conference Explores Industry Changes in CPOE and Electronic Health Records

SAN DIEGO, Oct. 11 /PRNewswire/ -- Implementing and demonstrating "meaningful use" of acute care Electronic Health Records, and other industry changes impacting hospital information technology, will be the focus of the annual Allscripts (Nasdaq: MDRX) acute care users conference for executives and healthcare professionals at hospitals and healthcare organizations across the globe.

A record number of users of the Sunrise EnterpriseTM integrated clinical suite are in San Diego for the conference, Oct. 10-13. Nearly 1,500 attendees representing 240 healthcare organizations -- including 23 international organizations -- will meet with Allscripts solution experts, collaborate, network and share best practices for optimizing use of their Allscripts solutions including acute care Electronic Health Record (EHR), computerized physician order entry (CPOE), revenue cycle solutions, patient access and more.

"Coming just two months after our merger with Eclipsys and our recent Allscripts users conference, which drew a record 3,500 attendees, this week's conference provides our Sunrise clients with an opportunity to get to know the new Allscripts, to network, attend classes and learn about our roadmap for helping them achieve 'meaningful use' with the Sunrise Enterprise integrated clinical suite -- and our other electronic health records for hospitals and physicians," said Mr. Glen Tullman. "And we're proud to share a number of innovations that will enable our clients to improve access to information and improve coordination of patient care for providers."

The conference features more than 100 sessions presented by clients, Allscripts leadership and solutions experts, and industry thought leaders, in addition to demonstrations of new solutions and numerous opportunities for clients to collaborate and provide feedback to Allscripts. Glen Tullman, Chief Executive Officer of Allscripts, and Phil Pead, Allscripts Chairman and former CEO of Eclipsys (which merged with Allscripts in August 2010), will kick off the conference this morning with an opening session designed to share the company's vision for the future of healthcare transformation.

The conference's featured speaker is General Colin Powell, 65th Secretary of State and National Security Advisor to President Reagan, who will focus on lessons in leadership applicable to healthcare executives.

New Solutions Announced: Sunrise Mobile MD and Allscripts Developer Program with Allscripts Application Store & Exchange

Attendees will be the first to see two new innovations: Sunrise Mobile MDTM, an intuitive and easy-to-use iPhone application that enhances the way physicians deliver care for hospitalized patients; and the Allscripts Developer ProgramTM (ADP), a new program that provides an opportunity for clients and third parties to natively integrate their applications with Allscripts clinical and business performance solutions. Coming in December, clients will be able to search the new Allscripts Application Store & Exchange (ASX) to select or share applications developed through the ADP.

Sunrise Mobile MD, the latest in a series of clinically focused mobile applications from Allscripts, is an integrated extension of Sunrise Enterprise, which features the leading acute care Electronic Health Record (EHR) and CPOE system.  Designed to work natively on an Apple iPhone® or iPod touch®, Sunrise Mobile MD enables physicians to access and act upon rich patient data whenever and wherever they need it, improving workflow and productivity.  Thanks to its comprehensive integration with Sunrise, updates to patient information made within the electronic record are reflected in Sunrise Mobile MD in real-time, ensuring that physicians are acting upon the most current information available.

Sunrise Mobile MD delivers iconic, user-friendly graphical presentation of patient rounding information including patient summaries, administrative information, orders and notifications. Physicians using the Allscripts iPhone application gain direct access to and from the Allscripts Sunrise Enterprise EHR database, including the same security, auditing and sign-on capabilities. Any updates made in Sunrise Enterprise are reflected in the mobile device in real time.

"Sunrise Mobile MD promises to give the physicians what they have been asking for since moving to an EHR; convenient, instant access to current patient information anywhere, anytime," said Steve Margolis, M.D., Chief Medical Informatics Officer of Orlando Health in Orlando, FL. "Because it shares the same database with the Sunrise Enterprise EHR, it will be an efficient technology for hospitals to install and deploy. For Sunrise Enterprise hospital systems vying to win the affinity of physicians within their market, this new offering could prove an invaluable competitive advantage to better manage relationships with referring physicians, increase referrals or obtain referrals from new physicians."

Designed with powerful features to dramatically streamline physician workflow and improve day-to-day experience, the solution sets the stage for physicians to view Sunrise Mobile MD-enabled Allscripts hospitals as preferred medical centers -- hospitals concerned not only with improving the quality of patient care, but improving the physician's clinical experience.  

Allscripts Developer Program and Allscripts Application Store & Exchange: Avoiding "Rip and Replace" Syndrome

The Allscripts Application Store & Exchange (ASX) is an online marketplace accessible within ClientConnect, the online community for Sunrise clients.  ASX enables clients to learn about and select a wide range of applications including third-party and client-built applications developed by registered, approved members of the Allscripts Developer Program.  The developer program, in turn, leverages Helios by Allscripts, an open architecture platform built into Sunrise Enterprise 5.5 that eliminates the need for software interfaces, providing a cost of ownership that is dramatically lower than a single-vendor system with a closed proprietary architecture.  

By enabling Allscripts clients to easily locate and exchange technologies that are natively integrated with Sunrise Enterprise, ASX protects their existing technology investments and helps avoid expensive "rip and replace" situations.  

"Allscripts believes in enabling change, not restricting it. The Allscripts Developer Program and Application Store and Exchange is a direct response to our clients' need for lower cost of ownership, integration and choice, and the latest example of the Allscripts commitment to open systems and open architecture as opposed to the closed systems offered by some of our competitors," said John Gomez, President of Product Strategy and Development for Allscripts.  "Through ASX, our clients will be able to find integrated applications developed by other clients and registered Allscripts partners, allowing them to quickly overcome the limitations of their current IT systems rather than investing in entirely new systems."

ASX will be available to Sunrise clients in December, 2010. In the meantime, interested Allscripts clients and partners are encouraged to register for the Allscripts Developer Program by visiting or by emailing [email protected].

About Allscripts

Allscripts (Nasdaq: MDRX) provides innovative solutions that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company's clinical, financial, connectivity and information solutions for hospitals, physicians and post-acute organizations are the essential technologies that enable a connected healthcare community. To learn more about Allscripts, please visit, Twitter, Facebook and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition.

Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-K for the fiscal year ended May 31, 2010 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.